Visceral Leishmaniasis Associated with B-Cell Chronic Lymphocytic Leukemia: Report of a Case and Review of the Literature

Infections often complicate the course of hematological diseases and may represent a diagnostic challenge. In particular, visceral leishmaniasis diagnosis may be missed in lymphoma patients, as lymphoma-related immunosuppression can lead to a misleadingly negative Leishmania serology and to atypical clinical manifestations, including the lack of fever, considered a common symptom in leishmaniasis. Herein, we report a case of visceral leishmaniasis in a patient with a long history of B-cell chronic lymphocytic leukemia presenting with increasing fatigue and diarrhea, in the absence of fever. Leishmania serology was negative. Bone marrow biopsy performed with the clinical suspicion of transformation to high-grade lymphoma disclosed intracytoplasmic inclusion bodies resembling Leishmania amastigotes within the cytoplasm of macrophages, and CD1a immunohistochemical expression helped to confirm the diagnosis of leishmaniasis. Liposomal amphotericin B was administered with complete symptom resolution. The correct identification of Leishmania is critical as visceral leishmaniasis represents a severe disease with an often fatal outcome, particularly in frail patients, unless promptly recognized and adequately treated. A review of the literature of visceral leishmaniasis cases occurring in B-cell chronic lymphocytic leukemia patients is performed.

[1]  S. Ascani,et al.  Primary effusion lymphoma occurring in the setting of transplanted patients: a systematic review of a rare, life-threatening post-transplantation occurrence , 2021, BMC cancer.

[2]  H. Eshaghi,et al.  Visceral Leishmaniasis: Kala‐azar , 2020, Diagnostic cytopathology.

[3]  M. Bagot,et al.  Visceral leishmaniasis in patients with lymphoma , 2020, Medicine.

[4]  S. Ascani,et al.  Clinical, pathological and molecular features of plasmablastic lymphoma arising in the gastrointestinal tract: A review and reappraisal. , 2020, Pathology, research and practice.

[5]  S. Ascani,et al.  Seronegative visceral leishmaniasis with bone marrow and hepatic involvement. , 2019, Blood.

[6]  P. Leboit,et al.  Is CD1a useful for leishmaniasis diagnosis in the New World? , 2018, Journal of cutaneous pathology.

[7]  G. Khoury,et al.  Leishmania in a Patient with Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia , 2018, The American journal of case reports.

[8]  J. North,et al.  Histopathologic features of cutaneous leishmaniasis and use of CD1a staining for amastigotes in Old World and New World leishmaniasis , 2017, Journal of cutaneous pathology.

[9]  M. Salavert,et al.  Is Visceral Leishmaniasis Different in Immunocompromised Patients Without Human Immunodeficiency Virus? A Comparative, Multicenter Retrospective Cohort Analysis. , 2017, The American journal of tropical medicine and hygiene.

[10]  J. Rodríguez-Peralto,et al.  Morphological and immunohistochemical clues for the diagnosis of cutaneous leishmaniasis and the interpretation of CD1a status. , 2016, Journal of the American Academy of Dermatology.

[11]  R. López-Vélez,et al.  Leishmaniasis in immunosuppressed individuals. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[12]  A. Malfitano,et al.  Visceral leishmaniasis mimicking Richter transformation , 2014, Leukemia & lymphoma.

[13]  G. Altavilla,et al.  Visceral leishmaniasis after alemtuzumab in a patient with chronic lymphocytic leukaemia , 2012, British journal of haematology.

[14]  E. Ferroglio,et al.  Seronegative visceral leishmaniasis with relapsing and fatal course following rituximab treatment , 2011, Infection.

[15]  M. Ostronoff,et al.  Coexistence of Leishmaniasis and Hodgkin's lymphoma in a lymph node. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  S. Antinori,et al.  Clinical use of polymerase chain reaction performed on peripheral blood and bone marrow samples for the diagnosis and monitoring of visceral leishmaniasis in HIV-infected and HIV-uninfected patients: a single-center, 8-year experience in Italy and review of the literature. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  K. Naresh,et al.  Burkitt lymphoma and Leishmaniasis in the same tissue sample in an AIDS patient , 2006, Histopathology.

[18]  J. Berman,et al.  Advances in leishmaniasis , 2005, The Lancet.